Khiron first Colombian Cannabis company to ship clones to the EU

Marijuana Staff

13 Mar 2021

Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that the Company has successfully exported its registered Colombian cannabis strains, in the form of live clones, to Europe.

Original release: www.prnewswire.com/news-releases/khiron-becomes-first-colombian-medical-cannabis-company-to-export-live-cannabis-clones-to-europe-301245194.html

OCB Rolling Papers Blazes New World Record at Hall of Flowers

The record attempt was part of the larger Hall of Flowers event, which attracted over 13,000 attendees and featured more than 300 vendors.

Medical Cannabis in South Australia: Progress and Pitfalls

These changes represent real progress for patients who can access and afford MC products. They promise to reduce stigma, improve daily life, and potentially expand treatment options.

California Cracks Down on Unregulated Hemp Products with New Emergency Regulations

The hemp industry, which has operated in a grey area, will need to quickly adapt to these new rules.

Global Pre-Roll Market Boom: Insights and Challenges for Australian Cannabis Industry

A significant challenge facing Australian cannabis operators is the current prohibition of pre-rolls in the legal medical cannabis space.

Read more

OCB Rolling Papers Blazes New World Record at Hall of Flowers

Medical Cannabis in South Australia: Progress and Pitfalls

California Cracks Down on Unregulated Hemp Products with New Emergency Regulations

Global Pre-Roll Market Boom: Insights and Challenges for Australian Cannabis Industry